# Electrocautery Ablation for the Prevention of Lung Cancer

> **NCT03870152** · PHASE2,PHASE3 · TERMINATED · sponsor: **University College, London** · enrollment: 13 (actual)

## Conditions studied

- Lung Cancer Squamous Cell

## Interventions

- **PROCEDURE:** Electrocautery Ablation (EC)

## Key facts

- **NCT ID:** NCT03870152
- **Lead sponsor:** University College, London
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2020-10-29
- **Primary completion:** 2022-09-02
- **Final completion:** 2022-10-11
- **Target enrollment:** 13 (ACTUAL)
- **Why stopped:** This decision was made due to lower than expected recruitment levels into the trial
- **Last updated:** 2022-10-31

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03870152

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03870152, "Electrocautery Ablation for the Prevention of Lung Cancer". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03870152. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*